Naoto Omata Selected Research

Naoto Omata Research Topics

5	Narcolepsy 04/2022 - 01/2015
3	Cataplexy 12/2018 - 01/2015
3	Mood Disorders (Mood Disorder) 05/2015 - 08/2013
2	Idiopathic Hypersomnia 04/2022 - 01/2015
2	Disorders of Excessive Somnolence (Hypersomnia) 12/2018 - 02/2015
2	Parkinsonian Disorders (Parkinsonism) 10/2007 - 05/2007
2	Tardive Dyskinesia 10/2007 - 05/2007
2	Hypoxia (Hypoxemia) 12/2003 - 02/2002
1	Sialorrhea 02/2017
1	Sleep Wake Disorders 02/2015
1	Mania (Manias) 08/2013
1	Hepatic Encephalopathy 03/2013
1	Ischemia 11/2012
1	Movement Disorders (Movement Disorder) 05/2007
1	Parkinson Disease (Parkinson's Disease) 05/2007
1	Mental Disorders (Mental Disorder) 01/2007
1	Atherosclerosis 08/2006
1	Delirium 01/2003
1	Brain Hypoxia (Cerebral Hypoxia) 02/2002

4	HLA-DQB1 antigen (HLA DQB1)IBA 01/2022 - 01/2015
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 02/2015
3	Antidepressive Agents (Antidepressants)IBA 11/2013 - 08/2006
3	Glucose (Dextrose)FDA LinkGeneric 03/2013 - 02/2002
3	Antipsychotic Agents (Antipsychotics)IBA 10/2007 - 01/2007
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2012 - 12/2003
1	OrexinsIBA 04/2022
1	Ointments (Pastes)IBA 02/2017
1	Scopolamine (Hyoscine)FDA Link 02/2017
1	Clozapine (Clozaril)FDA LinkGeneric 02/2017
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2015
1	AmmoniaIBA 03/2013
1	Dizocilpine Maleate (Dizocilpine)IBA 11/2012
1	ZincIBA 11/2012
1	NeurotoxinsIBA 05/2007
1	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 05/2007
1	Free Radical ScavengersIBA 12/2003
1	Neuroprotective AgentsIBA 12/2003
1	LithiumIBA 01/2003
1	3-nitropropionic acidIBA 02/2002
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2002

2	Therapeutics 08/2013 - 08/2006